Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery

Radiotherapy and Oncology

Volumn 103, Issue 2, 2012, Pages 199-205

  Terrazzino, Salvatore ^a   Mattina, Pierdaniele La ^a   Masini, Laura ^a   Caltavuturo, Tina ^a   Gambaro, Giuseppina ^a   Canonico, Pier Luigi ^a   Genazzani, Armando A ^a   Krengli, Marco ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Acute skin reaction; Breast cancer; Radiotherapy; Single nucleotide polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE P1; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN MSH2; PROTEIN MSH3; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CELL PROLIFERATION; FIBROBLAST; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PARTIAL MASTECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REAL TIME ECHOGRAPHY; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TOXICITY;

AGED; BREAST NEOPLASMS; DNA-BINDING PROTEINS; DOSE FRACTIONATION; FEMALE; GENOTYPE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SKIN;

EID: 84860433204     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.12.002     Document Type: Article

References (29)

1. J.B. Schnur, S.C. Ouellette, T.A. Dilorenzo, S. Green, and G.H. Montgomery A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients Psychooncology 2 2011 260 268
2. S.M. Bentzen, and J. Overgaard Patient-to-patient variability in the expression of radiation-induced normal tissue injury Semin Radiat Oncol 4 1994 68 80
3. D. Twardella, O. Popanda, and I. Helmbold Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy Radiother Oncol 69 2003 145
4. I. Turesson, J. Nyman, E. Holmberg, and A. Odén Prognostic factors for acute and late skin reactions in radiotherapy patients Int J Radiat Oncol Biol Phys 36 1996 1065
5. D. Porock, L. Kristjanson, S. Nikoletti, F. Cameron, and P. Pedler Predicting the severity of radiation skin reactions in women with breast cancer Oncol Nurs Forum 25 1998 1019 1029
6. M. Back, M. Guerrieri, C. Wratten, and A. Teigler Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer Clin Oncol 16 2004 12 16
7. J. Chang-Claude, O. Popanda, and X.L. Tan Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients Clin Cancer Res 11 2005 4802 4809
8. X.L. Tan, O. Popanda, and C.B. Ambrosone Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients Breast Cancer Res Treat 97 2006 255 262
9. M. Mangoni, S. Bisanzi, and F. Carozzi Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients Int J Radiat Oncol Biol Phys 81 2011 52 58
10. L. Zhou, J. Xia, H. Li, J. Dai, and Y. Hu Association of XRCC1 variants with acute skin reaction after radiotherapy in breast cancer patients Cancer Biother Radiopharm 25 2010 681 685
11. C.B. Ambrosone, C. Tian, and J. Ahn Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study Breast Cancer Res 8 2006 R40
12. J. Ahn, C.B. Ambrosone, and P.A. Kanetsky Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer Clin Cancer Res 12 2006 7063 7070
13. L. Zhang, M. Yang, and N. Bi Association of TGF-β1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy Radiother Oncol 97 2010 19 25
14. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
15. S. Sterpone, T. Cornetta, and L. Padua DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients Mutat Res 684 2010 43 48
16. N. Moullan, D.G. Cox, S. Angèle, P. Romestaing, J.P. Gérard, and J. Hall Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy Cancer Epidemiol Biomarkers Prev 12 2003 1168 1174
17. C.N. Andreassen, J. Alsner, M. Overgaard, and J. Overgaard Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes Radiother Oncol 69 2003 127 135
18. C.N. Andreassen, J. Alsner, J. Overgaard, C. Herskind, J. Haviland, and R. Owen TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer Radiother Oncol 75 2005 18 21
19. G. Giotopoulos, R.P. Symonds, K. Foweraker, M. Griffin, I. Peat, and A. Osman The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes Br J Cancer 96 2007 1001 1007
20. Sterpone S, Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J Nucleic Acids 2010; doi:10.4061/2010/780369.
21. B. Hao, X. Miao, and Y. Li A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity, increased risk of non-small cell lung cancer Oncogene 25 2006 3613
22. J.H. Martin, O. Alalami, and H.W. van den Berg Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence Cancer Lett 144 1999 65 74
23. B.A. Veldman, W. Spiering, and P.A. Doevendans The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide J Hypertens 20 2002 2023 2027
24. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity - are we on the right track? Radiother Oncol 97 2010 1 8
25. M.A. Babyak What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models Psychosom Med 66 2004 411 421
26. S.M. Bentzen, M. Parliament, and J.O. Deasy Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects Int J Radiat Oncol Biol Phys 76 2010 S145 S150
27. S. Quarmby, H. Fakhoury, and E. Levine Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients Int J Radiat Biol 79 2003 137 143
28. C.N. Andreassen, and J. Alsner Genetic variants and normal tissue toxicity after radiotherapy: a systematic review Radiother Oncol 92 2009 299 309
29. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study Radiother Oncol 97 2010 9 14